Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Wit, Ferdinand"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-6 z 6
    Tytuł:
    Adoption is not associated with immunological and virological outcomes in children with perinatally acquired HIV infection in the Netherlands.
    Autorzy:
    Van Den Hof M; Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
    Smit C; HIV Monitoring Foundation, Amsterdam, the Netherlands.
    Rossum AMCV; Department of Paediatrics, Sophia Children's Hospital, ErasmusMC, Rotterdam, the Netherlands.
    Fraaij PLA; Department of Paediatrics, Sophia Children's Hospital, ErasmusMC, Rotterdam, the Netherlands.
    Wolfs TFW; Department of Paediatrics, Wilhelmina Children's Hospital, Utrecht, the Netherlands.
    Geelen SPM; Department of Paediatrics, Wilhelmina Children's Hospital, Utrecht, the Netherlands.
    Scherpbier HJ; Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
    Schölvinck EH; Department of Paediatrics, Beatrix Children's Hospital, University Medical Centre Groningen, Groningen, the Netherlands.
    Aerde KV; Department of Paediatrics, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, the Netherlands.
    Reiss P; HIV Monitoring Foundation, Amsterdam, the Netherlands.; Department of Global Health, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
    Wit FWNM; HIV Monitoring Foundation, Amsterdam, the Netherlands.; Department of Global Health, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam Infection and Immunity Institute, Amsterdam, the Netherlands.
    Pajkrt D; Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
    Pokaż więcej
    Corporate Authors:
    ATHENA cohort study group
    Źródło:
    PloS one [PLoS One] 2023 May 04; Vol. 18 (5), pp. e0284395. Date of Electronic Publication: 2023 May 04 (Print Publication: 2023).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    HIV Infections*/drug therapy
    HIV Infections*/epidemiology
    Anti-HIV Agents*/therapeutic use
    Humans ; Child ; Prospective Studies ; Netherlands/epidemiology ; Antiretroviral Therapy, Highly Active ; Viral Load
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
    Autorzy:
    Byonanebye DM; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.; School of Public Health, Makerere University, Kampala, Uganda.
    Polizzotto MN; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
    Neesgaard B; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
    Sarcletti M; Department of Dermatology, Venerology and Allergology, Medical University Innsbruck, Innsbruck, Austria.
    Matulionyte R; Department of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.
    Braun DL; Division of Infectious Diseases and Hospital Epidemiology, Switzerland Swiss HIV Cohort Study (SHCS), Institute of Medical Virology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
    Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.
    de Wit S; CHU Saint Pierre, Infectious Diseases, Université Libre de Bruxelles, Brussels, Belgium.
    Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands.
    Fontas E; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France.
    Vehreschild JJ; Medical Department 2, Hematology/Oncology, University Hospital of Frankfurt, Frankfurt, Germany.; Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany.
    Vesterbacka J; Swedish InfCare HIV Cohort, Karolinska University Hospital, Huddinge, Sweden.
    Greenberg L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK.
    Hatleberg C; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
    Garges H; ViiV Healthcare, RTP, North Carolina, USA.
    Gallant J; Gilead Sciences, Foster City, California, USA.
    Volny Anne A; EATG European AIDS Treatment Group, Brussels, Belgium.
    Öllinger A; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
    Mozer-Lisewska I; Poznan University of Medical Sciences, Poznan, Poland.
    Surial B; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
    Spagnuolo V; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.
    Necsoi C; CHU Saint Pierre, Infectious Diseases, Université Libre de Bruxelles, Brussels, Belgium.
    van der Valk M; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands.; Division of Infectious Diseases, Department of Internal Medicine, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
    Mocroft A; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK.
    Law M; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
    Ryom L; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
    Petoumenos K; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
    Pokaż więcej
    Corporate Authors:
    RESPOND study group
    Źródło:
    HIV medicine [HIV Med] 2022 Sep; Vol. 23 (8), pp. 895-910. Date of Electronic Publication: 2022 Mar 01.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Anti-HIV Agents*/adverse effects
    HIV Infections*/complications
    HIV Infections*/drug therapy
    HIV Integrase Inhibitors*/adverse effects
    Hypertension*/chemically induced
    Hypertension*/epidemiology
    Adolescent ; Adult ; Aged, 80 and over ; Anti-Retroviral Agents/therapeutic use ; Humans ; Incidence ; Integrase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Autorzy:
    Bijker R; Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
    Jiamsakul A; The Kirby Institute, Biostatistics and Databases Program, UNSW Australia, Sydney, NSW, Australia.
    Kityo C; Joint Clinical Research Centre, Kampala, Uganda.
    Kiertiburanakul S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Siwale M; Lusaka Trust Hospital, Lusaka, Zambia.
    Phanuphak P; HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
    Akanmu S; College of Medicine, University of Lagos, Lagos, Nigeria.
    Chaiwarith R; Division of Infectious Diseases, Department of Medicine, Research Institute for Health Sciences, Chiang Mai, Thailand.
    Wit FW; Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
    Sim BL; Infectious Disease Unit, Department of Medicine, Hospital Sungai Buloh, Sungai Buloh, Malaysia.
    Boender TS; Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
    Ditangco R; Research Institute for Tropical Medicine, Manila, Philippines.
    Rinke De Wit TF; Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
    Sohn AH; TREAT Asia/amfAR, The Foundation for AIDS Research, Bangkok, Thailand.
    Hamers RL; Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2017 Mar 03; Vol. 20 (1), pp. 21218.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Medication Adherence*
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    Adult ; Africa South of the Sahara/epidemiology ; Ambulatory Care Facilities ; Asia/epidemiology ; Cohort Studies ; Female ; HIV Infections/psychology ; Heterosexuality/psychology ; Heterosexuality/statistics & numerical data ; Humans ; Male ; Middle Aged ; Patient Compliance ; Prospective Studies ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study.
    Autorzy:
    Kayigamba FR; INTERACT, CPCD, PO Box 2181, Kigali, Rwanda.
    Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America.; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
    Bakker MI; Royal Tropical Institute, KIT Biomedical Research, Amsterdam, the Netherlands.
    Rodriguez CA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America.
    Bagiruwigize E; INTERACT, CPCD, PO Box 2181, Kigali, Rwanda.
    Wit FW; Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam, the Netherlands.; Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center (AMC), Amsterdam, the Netherlands.
    Rich ML; Partners In Health/Inshuti Mu Buzima, Rwinkwavu, Rwanda.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, United States of America.
    Schim van der Loeff MF; Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam, the Netherlands.; Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center (AMC), Amsterdam, the Netherlands.; Public Health Service of Amsterdam (GGD), Amsterdam, the Netherlands.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Jul 20; Vol. 11 (7), pp. e0159446. Date of Electronic Publication: 2016 Jul 20 (Print Publication: 2016).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Anti-HIV Agents/*therapeutic use
    Antiretroviral Therapy, Highly Active/*adverse effects
    HIV Infections/*drug therapy
    HIV Infections/*epidemiology
    CD4 Lymphocyte Count ; Female ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/pathogenicity ; Humans ; Male ; Middle Aged ; Rwanda ; Treatment Failure ; Viral Load/drug effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Temporary treatment during primary HIV infection does not affect virologic response to subsequent long-term treatment.
    Autorzy:
    Grijsen ML; Academic Medical Center, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam, Amsterdam, the Netherlands.
    Wit FW; Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
    Jurriaans S; Academic Medical Center, University of Amsterdam, Department of Medical Microbiology, Amsterdam, the Netherlands.
    Kroon FP; Leiden University Medical Center, Department of Infectious Diseases, Leiden, the Netherlands.
    Schippers EF; Haga Hospital, location Leyenburg, Department of Internal Medicine, The Hague, the Netherlands.
    Koopmans P; Radboud University Medical Center, Department of Internal Medicine, Nijmegen, the Netherlands.
    Gras L; HIV Monitoring Foundation, Amsterdam, the Netherlands.
    Lange JM; Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
    Prins JM; Academic Medical Center, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam, Amsterdam, the Netherlands.
    Pokaż więcej
    Corporate Authors:
    Primo-SHM Study Group
    Źródło:
    PloS one [PLoS One] 2014 Apr 03; Vol. 9 (4), pp. e89639. Date of Electronic Publication: 2014 Apr 03 (Print Publication: 2014).
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Drug Resistance, Viral*
    Anti-HIV Agents/*therapeutic use
    HIV Infections/*drug therapy
    HIV Infections/*virology
    HIV-1/*drug effects
    Viral Load/*drug effects
    Adult ; Drug Administration Schedule ; Female ; Follow-Up Studies ; HIV Infections/genetics ; HIV-1/genetics ; Humans ; Long-Term Care ; Male ; RNA, Viral/analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance: response.
    Autorzy:
    van Leth F
    Wit FW
    Lange JM
    Pokaż więcej
    Źródło:
    BMC medical research methodology [BMC Med Res Methodol] 2007 Mar 02; Vol. 7, pp. 14. Date of Electronic Publication: 2007 Mar 02.
    Typ publikacji:
    Letter; Comment
    MeSH Terms:
    Patient Compliance*
    Acquired Immunodeficiency Syndrome/*drug therapy
    Anti-HIV Agents/*administration & dosage
    Clinical Trials as Topic/*standards
    Nevirapine/*administration & dosage
    Oxazines/*administration & dosage
    Alkynes ; Benzoxazines ; Clinical Trials as Topic/methods ; Cyclopropanes ; Humans ; Research Design
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-6 z 6

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies